Also known as HER2-enriched breast cancer, HER2-positive breast cancer represents 15–20% of all breast cancers [18,19] and are dependent on the high expression of HER2 oncoprotein, and its intensive downstream signaling pathways [21]. The gene discussed is ERBB2; the disease is breast cancer.